FI943103A0 - Puolikiinteä farmaseuttinen aine ja menetelmä sen valmistamiseksi - Google Patents

Puolikiinteä farmaseuttinen aine ja menetelmä sen valmistamiseksi

Info

Publication number
FI943103A0
FI943103A0 FI943103A FI943103A FI943103A0 FI 943103 A0 FI943103 A0 FI 943103A0 FI 943103 A FI943103 A FI 943103A FI 943103 A FI943103 A FI 943103A FI 943103 A0 FI943103 A0 FI 943103A0
Authority
FI
Finland
Prior art keywords
semi
solid pharmaceutical
preparation
pharmaceutical substance
bioactive substance
Prior art date
Application number
FI943103A
Other languages
English (en)
Swedish (sv)
Other versions
FI943103A (fi
Inventor
Masao Ikeda
Tomoki Tatefuji
Hiroshi Yamauchi
Original Assignee
Hayashibara Biochem Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hayashibara Biochem Lab filed Critical Hayashibara Biochem Lab
Publication of FI943103A0 publication Critical patent/FI943103A0/fi
Publication of FI943103A publication Critical patent/FI943103A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/15—Suppositories

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
FI943103A 1993-06-28 1994-06-28 Puolikiinteä farmaseuttinen aine ja menetelmä sen valmistamiseksi FI943103A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5178614A JPH0776527A (ja) 1993-06-28 1993-06-28 半固形製剤とその製造方法

Publications (2)

Publication Number Publication Date
FI943103A0 true FI943103A0 (fi) 1994-06-28
FI943103A FI943103A (fi) 1994-12-29

Family

ID=16051528

Family Applications (1)

Application Number Title Priority Date Filing Date
FI943103A FI943103A (fi) 1993-06-28 1994-06-28 Puolikiinteä farmaseuttinen aine ja menetelmä sen valmistamiseksi

Country Status (13)

Country Link
US (1) US5489577A (fi)
EP (1) EP0630651B1 (fi)
JP (1) JPH0776527A (fi)
KR (1) KR100314820B1 (fi)
AT (1) ATE199646T1 (fi)
AU (1) AU685111B2 (fi)
CA (1) CA2126932A1 (fi)
DE (1) DE69426844T2 (fi)
DK (1) DK0630651T3 (fi)
FI (1) FI943103A (fi)
NZ (1) NZ260867A (fi)
PT (1) PT630651E (fi)
TW (1) TW496744B (fi)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0748630B1 (en) * 1994-12-29 2002-04-03 Mochida Pharmaceutical Co., Ltd. Ulinastatin-containing suppository
JP2001064181A (ja) * 1999-08-27 2001-03-13 Otsuka Pharmaceut Co Ltd 免疫賦活組成物
JP4866519B2 (ja) * 2001-09-21 2012-02-01 天藤製薬株式会社 坐剤の製造法
JP4866518B2 (ja) * 2001-09-21 2012-02-01 天藤製薬株式会社 坐剤の製造法
NZ523100A (en) * 2002-12-10 2005-02-25 Fonterra Co Operative Group A process for producing a carbohydrate composition
DE102004022928A1 (de) * 2004-05-10 2005-12-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pulver enthaltend neuartige Oligosacharidgemische und Verfahren zu deren Herstellung
DE102004022927A1 (de) * 2004-05-10 2005-12-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg 1,4 O-verknüpfte Saccharose-Derivate zur Stabilisierung von Antikörpern oder Antikörper-Derivaten
US7723306B2 (en) 2004-05-10 2010-05-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Spray-dried powder comprising at least one 1,4 O-linked saccharose-derivative and methods for their preparation
US7611709B2 (en) 2004-05-10 2009-11-03 Boehringer Ingelheim Pharma Gmbh And Co. Kg 1,4 O-linked saccharose derivatives for stabilization of antibodies or antibody derivatives
DE102004022926A1 (de) * 2004-05-10 2005-12-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Sprühgetrocknete Pulver enthaltend zumindest ein 1,4 O-verknüpftes Saccharose-Derivat und Verfahren zu deren Herstellung
US7727962B2 (en) 2004-05-10 2010-06-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Powder comprising new compositions of oligosaccharides and methods for their preparation
DE102006053375A1 (de) * 2006-11-10 2008-05-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Mischung von Pulvern

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2042888B (en) * 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
DE3273597D1 (en) * 1981-11-28 1986-11-06 Sunstar Kk Pharmaceutical composition containing interferon in stable state
US4447355A (en) * 1982-04-07 1984-05-08 Asahi Kasei Kogyo Kabushiki Kaisha Method for stabilizing a tumor necrosis factor and a stable aqueous solution or powder containing the same
US4659696A (en) * 1982-04-30 1987-04-21 Takeda Chemical Industries, Ltd. Pharmaceutical composition and its nasal or vaginal use
JPS5921613A (ja) * 1982-07-28 1984-02-03 Takeda Chem Ind Ltd 直腸投与製剤
US4650665A (en) * 1985-02-08 1987-03-17 Ethicon, Inc. Controlled release of pharmacologically active agents from an absorbable biologically compatible putty-like composition
US4593038A (en) * 1985-04-03 1986-06-03 Burzynski Stanislaw R Topical use of 3-phenylacetylamino-2,6-piperidinedione for treatment of skin wrinkles and hyperpigmentation
US5288497A (en) * 1985-05-01 1994-02-22 The University Of Utah Compositions of oral dissolvable medicaments
US4870059A (en) * 1985-11-27 1989-09-26 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Dehydration of hydrous matter with anhydrous maltose
US4851220A (en) * 1986-11-26 1989-07-25 Schering Corporation Stable oleaginous gel
EP0534286B1 (en) * 1987-03-06 1995-08-02 Kao Corporation External skin care preparation
HU203204B (en) * 1987-09-15 1991-06-28 Sandoz Ag Process for producing suppository containing calcitonin and taurocholic acid
DE3731255A1 (de) * 1987-09-17 1989-04-06 Boehringer Ingelheim Int Stabilisierung von therapeutisch wirksamen proteinen in pharmazeutischen zubereitungen
US5266310A (en) * 1987-09-17 1993-11-30 Boehringer Ingelheim International Gmbh Stabilization of therapeutically active proteins in pharmaceutical preparations
US5215743A (en) * 1988-04-13 1993-06-01 Maninder Singh Tumor necrosis factor formulations
US5011824A (en) * 1988-11-16 1991-04-30 Kyowa Hakko Kogyo Co., Ltd. Rectal motilin preparation
EP0399432B1 (en) * 1989-05-25 1994-06-22 Takeda Chemical Industries, Ltd. Transdermal therapeutic composition
JP2945993B2 (ja) * 1989-12-05 1999-09-06 武田薬品工業株式会社 外用剤
WO1991013601A1 (en) * 1990-03-15 1991-09-19 Rhône-Poulenc Rorer International (Holdings) Inc. Calcitonin suppository formulations
US5194261A (en) * 1990-11-27 1993-03-16 Virgil Pichierri Diaper rash treatment
WO1992014479A1 (en) * 1991-02-19 1992-09-03 Tsumura & Co. Composition for rectal administration of difficultly absorbable peptide
IT1244500B (it) * 1991-03-21 1994-07-15 Pulitzer Italiana Impiego di sali minerali di trometamina in composizioni farmaceutiche a base di calcitonina somministrabili per via rettale in terapia umana
US5318780A (en) * 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels

Also Published As

Publication number Publication date
PT630651E (pt) 2001-06-29
EP0630651A3 (en) 1996-11-06
KR950000168A (ko) 1995-01-03
US5489577A (en) 1996-02-06
AU6601994A (en) 1995-01-05
TW496744B (en) 2002-08-01
CA2126932A1 (en) 1994-12-29
FI943103A (fi) 1994-12-29
AU685111B2 (en) 1998-01-15
DE69426844T2 (de) 2001-08-23
DK0630651T3 (da) 2001-04-17
EP0630651B1 (en) 2001-03-14
EP0630651A2 (en) 1994-12-28
JPH0776527A (ja) 1995-03-20
DE69426844D1 (de) 2001-04-19
KR100314820B1 (ko) 2002-06-20
NZ260867A (en) 1996-01-26
ATE199646T1 (de) 2001-03-15

Similar Documents

Publication Publication Date Title
EP0221041A3 (en) Benzimidazole derivatives, process for their preparation and their pharmaceutical use
HUT43948A (en) Emulsion compositions for dosing ionizable hydrophobic medical substances which are little soluble in water and process for preparing the same
IL86221A0 (en) Drug delivery compositions and method of making the same
KR830002327A (ko) 약학적 제제
IE830207L (en) Fibrinogen formulation
CA2058835A1 (en) Stable pharmaceutical composition and method for its production
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
FI943103A0 (fi) Puolikiinteä farmaseuttinen aine ja menetelmä sen valmistamiseksi
NL990012I2 (nl) Geneesmiddelen die salmeterol en fluticason bevatten.
ZA888734B (en) Stabilized medicinal substances,a process for the preparation thereof,and stable medicinal formulations
GR3003536T3 (fi)
DK62187D0 (da) Farmaceutisk praeparat indeholdende 3alfa-hydroxy-5beta-pregnan-20-on og fremstilling deraf
GR3006091T3 (fi)
HK38595A (en) Pharmaceutical preparation for the systemic treatment of toy fish and domestic fish
DE69004532D1 (de) Topisch anzuwendende Defibrotid enthaltende Arzneizubereitungen.
IL87778A0 (en) Pharmaceutical compositions containing stabilized therapeutically active proteins and their preparation
EP0271151A3 (en) Azumolene dosage form
DK0559682T3 (da) Topisk præparat
DK649487D0 (da) Praeparat til afgivelse af et topisk laegemiddel
ATE74521T1 (de) Durch ein lacton stabilisierte kosmetische und pharmazeutische harnstoffzubereitungen.
ES2007040A6 (es) Un forma de dosificacion para descargar un agente benificioso a un entorno fluido de uso
JPS6438027A (en) Remedy for cancer
ES464676A1 (es) Metodo de preparar productos farmaceuticos que pueden con- tener,por ejemplo,antibioticos y sustancias olorosas y aro- matizantes,tal como aroma de leche de cerda

Legal Events

Date Code Title Description
FD Application lapsed